Sehr Peter, Müller Martin, Höpfl Reinhard, Widschwendter Andreas, Pawlita Michael
Applied Tumor Virology, Deutsches Krebsforschungszentrum, Im Neuenheimer Feld 242, 69120, Heidelberg, Germany.
J Virol Methods. 2002 Oct;106(1):61-70. doi: 10.1016/s0166-0934(02)00134-9.
An alternative enzyme linked immunosorbent assay (ELISA) system was developed to analyze antibodies to human papillomavirus capsid antigens. The assay uses glutathione crosslinked to casein to capture the major capsid protein L1 from human papillomavirus (HPV) types 6b, 16 and 18 fused to glutathione S-transferase (GST) as antigen. The method allows efficient one-step purification of L1 fusion protein from crude bacterial lysates on ELISA plates coated with glutathione casein. The GST-L1 capture ELISA detected HPV 16 antibodies with high type specificity. Comparison with the current "gold-standard" for L1-serology that uses virus-like particles (VLP) as antigen demonstrated similar assay sensitivity. Pairwise comparison of the absorbance values of 105 human sera obtained in the two ELISA formats for HPV 16 showed a R(2) value of linear regression of 0.68. Conformity of the two ELISAs in classification of sera as HPV 16 L1 antibody-positive or -negative was verified with Cohen's kappa test, yielding a value of 0.62. These data indicate that the GST-L1 capture ELISA is similar in performance to the VLP ELISA. The ease of antigen production and purification in the GST-based ELISA will be advantageous to screen large sample numbers in vaccine trials or epidemiological studies examining immune responses to many HPV types in parallel.
开发了一种替代酶联免疫吸附测定(ELISA)系统来分析针对人乳头瘤病毒衣壳抗原的抗体。该测定法使用与酪蛋白交联的谷胱甘肽从与谷胱甘肽S-转移酶(GST)融合的6b、16和18型人乳头瘤病毒(HPV)中捕获主要衣壳蛋白L1作为抗原。该方法可在涂有谷胱甘肽酪蛋白的ELISA板上从粗细菌裂解物中高效一步纯化L1融合蛋白。GST-L1捕获ELISA以高型特异性检测HPV 16抗体。与使用病毒样颗粒(VLP)作为抗原的L1血清学当前“金标准”进行比较,显示出相似的测定灵敏度。对两种ELISA形式获得的105份人血清中HPV 16的吸光度值进行成对比较,线性回归的R(2)值为0.68。用科恩kappa检验验证了两种ELISA在将血清分类为HPV 16 L1抗体阳性或阴性方面的一致性,得出的值为0.62。这些数据表明GST-L1捕获ELISA的性能与VLP ELISA相似。基于GST的ELISA中抗原生产和纯化的简便性将有利于在疫苗试验或并行检查对多种HPV类型免疫反应的流行病学研究中筛选大量样本。